Abstract
The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (Tregs), yet how the microbiota-Treg cross-talk is physiologically controlled is incompletely defined. Here, we report that prostaglandin E2 (PGE2), a well-known mediator of inflammation, inhibits mucosal Tregs in a manner depending on the gut microbiota. PGE2 through its receptor EP4 diminishes Treg-favorable commensal microbiota. Transfer of the gut microbiota that was modified by PGE2-EP4 signaling modulates mucosal Treg responses and exacerbates intestinal inflammation. Mechanistically, PGE2-modified microbiota regulates intestinal mononuclear phagocytes and type I interferon signaling. Depletion of mononuclear phagocytes or deficiency of type I interferon receptor diminishes PGE2-dependent Treg inhibition. Together, our findings provide emergent evidence that PGE2-mediated disruption of microbiota-Treg communication fosters intestinal inflammation.
| Original language | English |
|---|---|
| Article number | eabd7954 |
| Number of pages | 16 |
| Journal | Science Advances |
| Volume | 7 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 12 Feb 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science.
Keywords
- Dinoprostone/pharmacology
- Gastrointestinal Microbiome
- Humans
- Inflammation
- Receptors, Prostaglandin E, EP2 Subtype
- T-Lymphocytes, Regulatory
Fingerprint
Dive into the research topics of 'Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver